G. Mastorakos et al., PRESENCE OF IMMUNOREACTIVE CORTICOTROPIN-RELEASING HORMONE IN NORMAL AND POLYCYSTIC HUMAN OVARIES, The Journal of clinical endocrinology and metabolism, 79(4), 1994, pp. 1191-1197
Recently, we demonstrated the presence of immunoreactive (Ir) CRH and
its receptors in the rat ovary. To determine whether CRH is also prese
nt in human ovaries, we examined ovaries from normal women and patient
s with the polycystic ovarian syndrome (PCOS). Immunoreactive CRH in n
ormal human ovaries had a similar distribution to that of rat ovarian
IrCRH, as determined by immunohistochemistry. Thus, immunoreactivity w
as intense in the cytoplasm of thecal cells surrounding the ovarian fo
llicles, in luteinized cells of the stroma, and in a subpopulation of
cells within the corpora lutes. No IrCRH was present in oocytes of pri
mordial follicles. Polycystic ovaries also had IrCRH in thecal cells;
however, CRH immunostaining was less prominent or completely absent fr
om the stroma or the sparsely present corpora lutes and was clearly de
tected in oocytes of primordial follicles. Using a specific RIA, the I
rCRH content in extracts of normal ovaries was higher than that in pol
ycystic ovaries (mean +/- so, 0.075 +/- 0.02 vs. 0.038 +/- 0.009 pmol/
g wet tissue, respectively; P < 0.05). Human follicular fluid samples
collected from women undergoing ovarian hyperstimulation for assisted
reproduction had low, but detectable, levels of IrCRH (mean +/- so, 4.
975 +/- 1.179 pmol/L), whereas IrCRH was undetectable in concurrently
drawn plasma samples. IrCRH detected in normal and polycystic ovaries
and in follicular fluid had similar chromatographic mobility to that o
f rat/human CRH-(1-41) by reverse phase HPLC. We conclude that IrCRH i
s present in normal human ovaries and follicular fluid, suggesting tha
t this neuropeptide may play a regulatory role in one or more of the v
arious functions of this gonad, such as ovulation and/or luteolysis, t
hrough its proinflammatory properties and/or its auto/paracrine regula
tion of:steroid biosynthesis, in analogy to its action on testosterone
secretion by the Leydig cell. Its decreased concentration and localiz
ation in primary oocytes of polycystic ovaries may he related to the i
ncreased androgen biosynthesis by the theca and stroma and/or to the o
ocyte dysfunction observed in women with the polycystic ovarian syndro
me, respectively.